Sort
78,016 grants matching “breast cancer”
Quantitative Ultrasonic Imaging of the Breast
$975,767William D. O'Brien · University Of Illinois At Urbana-Champaign · R01 · FY2007 · CA
Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial
$975,560Kathryn H. Schmitz · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
CALGB STUDIES OF BREAST CANCER IN THE ELDERLY
$975,261University Of Chicago · U10 · FY2000 · CA
Texas Center for Minority Health, Education, Research and Outreach
$975,149Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · U54 · FY2020 · MD
Beaumont Community Clinical Oncology Program
$975,009William Beaumont Hospital Research Inst · U10 · FY2002 · CA
MISMATCH REPAIR LOSS, THE IMMUNE ENVIRONMENT AND THE BREAST CANCER SECRETOME
$974,997San Diego State University Foundation · · FY2022 · Defense Health Agency
Genetic Epidemiology
$974,906Alisa Goldstein · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
Physical Activity, Energy Balance, and Cancer
$974,890Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases
$974,850Joel S. Bader · Johns Hopkins University · U01 · FY2018 · CA
SBIR Phase II: Innovative Protein Microarrays
$974,421Andrzej K Drukier · Biotraces Inc · · FY2004 · TIP
Genome-wide scan for genetic variants associated with early-onset prostate cancer
$974,415Kathleen A Cooney · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis
$974,241Kurt Kohn · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
LncRNA mechanisms in cancer
$974,029Howard Y Chang · Stanford University · R35 · FY2018 · CA
LncRNA mechanisms in cancer
$974,029Howard Y Chang · Stanford University · R35 · FY2017 · CA
A Phase I Study of Mistletoe Extract on PK, PD, and Safety of Gemcitabine in CA
$974,000Patrick J Mansky · Complementary & Integrative Health · Z01 · FY2007 · AT
Human natural killer cells: Advancing biology and clinical applications
$973,964Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2021 · CA
Human natural killer cells: Advancing biology and clinical applications
$973,964Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2020 · CA
Impact of Vaccination against GM2, GD2 and GD3 on Disease Free Survival in Resect
$973,936Wolfgang W Scholz · Mabvax Therapeutics, Inc. · R44 · FY2011 · CA
Preclinical Efficacy Evaluation of the Lipid-Based SMEDDS Formulation of DIM, BR-9001,
$973,931David McCormick · Iit Research Institute · N01 · FY2018 · CA
Biology of Mammary Gland Development and Tumorigenesis
$973,908Gilbert Smith · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
BREAST CANCER SELECTIVE THERAPEUTIC DEVELOPMENT: LEAD OPTIMIZATION OF A SMALL-MOLECULE INHIBITOR OF THE BREAST CANCER SELECTIVE HUB PROTEIN CAPCNA
$973,480Beckman Research Institute Of The City Of Hope · · FY2019 · Defense Health Agency
The CYGNET Study: Enviromental and Genetic Determinants of Maturation of Girls
$973,456Lawrence H Kushi · Kaiser Foundation Research Institute · U01 · FY2011 · ES
Breast Cancer Treatment Effectiveness in Older Women
$973,448Boston Medical Center · R01 · FY2004 · CA
Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer Therapy
$973,366Kate W Rittenhouse-Olson · For-Robin · R42 · FY2015 · CA
Breast and Ovary Cancer Clinical Validation Center
$973,064Christopher I Li · Fred Hutchinson Cancer Research Center · U01 · FY2012 · CA